Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Amortization of Deferred Charges (2016 - 2018)

Avalo Therapeutics' Amortization of Deferred Charges history spans 5 years, with the latest figure at -$24342.0 for Q4 2018.

  • For Q4 2018, Amortization of Deferred Charges fell 2434100.0% year-over-year to -$24342.0; the TTM value through Sep 2019 reached -$24342.0, down 107.44%, while the annual FY2018 figure was $302882.0, 1387.34% up from the prior year.
  • Amortization of Deferred Charges reached -$24342.0 in Q4 2018 per AVTX's latest filing, roughly flat from -$24342.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $246115.0 in Q2 2018 to a low of -$24342.0 in Q3 2018.
  • Average Amortization of Deferred Charges over 5 years is $48444.5, with a median of $36946.0 recorded in 2016.
  • The largest YoY upside for Amortization of Deferred Charges was 2990.73% in 2018 against a maximum downside of 2434100.0% in 2018.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $44292.0 in 2014, then surged by 100.91% to $88989.0 in 2015, then plummeted by 68.34% to $28174.0 in 2016, then tumbled by 100.0% to -$1.0 in 2017, then plummeted by 2434100.0% to -$24342.0 in 2018.
  • Per Business Quant, the three most recent readings for AVTX's Amortization of Deferred Charges are -$24342.0 (Q4 2018), -$24342.0 (Q3 2018), and $246115.0 (Q2 2018).